Altered blood rheology in the pathogenesis of diabetic and other neuropathies
Corresponding Author
Dr. Leslie O. Simpson MSc, PhD
Pathology Department, University of Otago Medical School, Dunedin, New Zealand
Pathology Department, University of Otago Medical School, P.O. Box 913, Dunedin, New ZealandSearch for more papers by this authorCorresponding Author
Dr. Leslie O. Simpson MSc, PhD
Pathology Department, University of Otago Medical School, Dunedin, New Zealand
Pathology Department, University of Otago Medical School, P.O. Box 913, Dunedin, New ZealandSearch for more papers by this authorAbstract
Although a substantial literature confirms the abnormal flow properties of diabetic blood, only in a few papers has the vasculitis of diabetic neuropathy been considered to have a hemorheological cause. It is proposed that the pathogenesis of nerve lesions involves an interaction between the specialized nerve vascular system and focal ischemic lesions resulting from rheologically induced stasis. The proposition is extended into other conditions with abnormal blood rheology such as hypothyroidism, uremia, dysglobulinemia, polyarteritis nodosa, and lepromatous leprosy. It is concluded that the treatment of such polyneuropathies should include an agent which would improve the flow properties of the blood.
References
- 1 Aherne WA: The “burr” red cell and azotaemia. J Clin Pathol 10: 252–257, 1957.
- 2 Arfors KE, Rutili G, Svensjo E: Microvascular transport of macro-molecules in normal and inflammatory conditions. Acta Physiol Scand (Suppl) 463: 93–103, 1979.
- 3
Barnes AJ,
Locke P,
Scudder PR,
Dormandy TL,
Dormandy JA,
Slack J:
Is hyperviscosity a treatable component of diabetic microcirculatory disease?
Lancet
ii: 789–791,
1977.
10.1016/S0140-6736(77)90724-3 Google Scholar
- 4 Behse F, Buchthal F, Carlsen F: Nerve biopsy and conduction studies in diabetic neuropathy. J Neurol Neurosurg Psychiatry 40: 1072–1082, 1977.
- 5 Bell MA, Weddell AGM: A descriptive study of the blood vessels of the sciatic nerve in the rat, man and other mammals. Brain 107: 871–898, 1984.
- 6 Bell MA, Weddell AGM: A morphometric study of infrafascicular vessels of mammalian sciatic nerve. Muscle Nerve 7: 524–534, 1984.
- 7 Boddingius J: Ultrastructural changes in blood vessels of peripheral nerves in leprosy neuropathy. II. Borderline, borderline-lepromatous and lepromatous leprosy patients. Acta Neuropathol 40: 21–39, 1977.
- 8 Bolton CF, Baltzan MA, Baltzan RB: Effects of renal transplantation on uremic neuropathy. A clinical and electrophysiologic study. N Engl J Med 284: 1170–1175, 1971.
- 9 Boulton AJM, Scarpello JHB, Ward JD: Venous oxygenation in the diabetic neuropathic foot: evidence of arteriovenous shunting? Diabetologia 22: 6–8, 1982.
- 10 Boulton AJM, Worth RC, Drury J, Hardisty CA, Wolf E, Cudworth AG, Ward JD: Genetic and metabolic studies in diabetic neuropathy. Diabetologia 26: 15–19, 1984.
- 11 Brown MJ, Asbury AK: Diabetic neuropathy. Ann Neurol 15: 2–12, 1984.
- 12 Cartwright IJ, Pockley AG, Galloway JH, Greaves M, Preston FE: The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythorocyte deformability and blood viscosity in healthy volunteers. Atherosclerosis 55: 267–281, 1985.
- 13 Chavers B, Etzwilar D, Michael AF: Albumin deposition in dermal capillary basement membrane in insulin dependent diabetes mellitus. A preliminary report. Diabetes 30: 275–278, 1981.
- 14 Chien S: Shear dependence of effective cell volume as a determinant of blood viscosity. Science 168: 977–979, 1970.
- 15 Cliff WJ: Observations on healing tissue: a combined light and electron microscopic investigation. Philos Trans Roy Soc Lond (Biol) 246: 305–325, 1963.
- 16 Cohen RD, Conn DL, Ilstrup DM: Clinical features, prognosis and response to treatment in polyarteritis. Mayo Clin Proc 55: 146–155, 1980.
- 17 Cohn R, Mauer M, Barbosa J, Michael A: Immunofluorescence studies of skeletal muscle extracellular membranes in diabetes mellitus. Lab Invest 39: 13–16, 1978.
- 18 Dayan AD, Gardner-Thorpe C, Down PF, Gleadle RI: Peripheral neuropathy in uremia. Pathological studies on peripheral nerves from 6 patients. Neurology (Minneap) 20: 649–658, 1970.
- 19 Decker JL (Moderator): Systemic lupus erythematosus. Contrasts and comparisons. Ann Intern Med 82: 391–404, 1975.
- 20 De Cree J, De Cock W, Geukens H, De Cierck F, Beerens M, Verhaegan H: The rheological effects of cinnarizine and flunarizine in normal and pathologic conditions. Angiology 30: 505–515, 1979.
- 21 Dintenfass L: Rheology of Blood in Diagnostic and Preventive Medicine. London, Butterworths, 1976.
- 22 Dintenfass L: Haemorheology of diabetes mellitus. Adv Microcirc 8: 14–36, 1979.
- 23 Ditzel J: The problem of tissue oxygenation in diabetes mellitus. III. The “three-in-one concept” for the development of diabetic microangiopathy and a rational approach to its prophylaxis. Acta Med Scand (Suppl) 578: 69–83, 1975.
- 24 Dodd HJ, Gaylarde PM, Sarkany I: Skin oxygen tension in venous insufficiency of the lower leg. J Roy Soc Med 78: 373–376, 1985.
- 25 Dormandy JA, Ernst E: Effects of buflomedil on erythrocyte deformability. Angiology 32: 714–716, 1981.
- 26 Dubois EL: Lupus Erythematosus, 2nd ed. Los Angeles, University of Southern California Press, 1974.
- 27 Dutta-Roy AK, Ray TK, Sinha AK: Control of erythrocyte membrane viscosity by insulin. Biochim Biophys Acta 816: 187–190, 1985.
- 28 Dyck PJ, Hansen S, Karnes J, O'Brien P, Yasuda H, Windebank A, Zimmerman B: Capillary number and percentage closed in human diabetic sural nerve. Proc Natl Acad Sci USA 82: 2513–2517, 1985.
- 29 Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lais A, Engelstad J: The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischaemia. Ann Neurol 19: 440–449, 1986.
- 30 Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R: Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425–429, 1986.
- 31 Dyck PJ, Lambert EH: Polyneuropathy associated with hypothryoidism. J Neuropathol Exp Neurol 29: 631–658, 1970.
- 32 Eyres L, Fenton D: A chemical and commercial background to evening primrose oil. Chem NZ April: 52–54, 1984.
- 33 Fagerberg SE: Diabetic neuropathy, a clinical and histological study on the significance of vascular affections. Acta Med Scand (Suppl) 345: 1–97, 1959.
- 34
Fahey JL,
Barth WF,
Solomon A:
Serum hyperviscosity syndrome.
J Am Med Assoc
192: 120–123,
1965.
10.1001/jama.1965.03080190030008 Google Scholar
- 35 Farquhar MG: Fine structure and function in capillaries of the anterior pituitary gland. Angiology 12: 270–292, 1961.
- 36 Federspiel WJ, Popel AS: A theoretical analysis of the effect of the particulate nature of blood on oxygen release in capillaries. Microvasc Res 32: 164–189, 1986.
- 37 Fisher RF: The water permeability of basement membrane under increasing pressure: evidence for a new theory of permeability. Proc R Soc Lond 216: 475–496, 1982.
- 38 Forman S, Bischel M, Hochstein P: Erythrocyte deformability in uremic hemodialysed patients. Ann Intern Med 79: 841–843, 1973.
- 39 Friederici HHR: Extrusion of basal endothelial projections through the capillary basement membrane. Angiology 16: 163–169, 1965.
- 40 Fukuhara N, Kumamoto T, Nakazawa Y, Tsubaki T: Blood-nerve barrier: effect of ligation of the peripheral nerve. Exp Neurol 63: 573–582, 1979.
- 41 Granger HJ, Shepherd AP: Intrinsic microvascular control of tissue oxygen delivery. Microvasc Res 5: 49–72, 1973.
- 42 Gunderson HJG, Christensen NJ: Intravenous insulin causing loss of intravascular water and albumin and increased adrenergic activity in diabetics. Diabetes 26: 551–557, 1977.
- 43 Hazelton RA, Lowe GDO, Forbes CD, Sturrock RD: Increased blood and plasma viscosity in systemic lupus erythematosus (SLE). J Rheumatol 12: 616–617, 1985.
- 44 Hellums JD: The resistance to oxygen transport in the capillaries relative to that in the surrounding tissue. Microvasc Res 13: 131–136, 1977.
- 45 Honigsmann H, Gschnait F, Konrad K, Stingl G, Wolff K: Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic porphyria-like skin lesions. J Invest Dermatol 66: 188–195, 1976.
- 46 Horrobin DF: The regulation of prostaglandin biosynthesis by the manipulation of essential fatty acid metabolism. Rev Pure Appl Pharmacol Sci 4: 339–432, 1983.
- 47 Houtsmuller AJ, van Hal-Ferwerda J, Zahn KJ, Henkes HE: Favourable influences of linoleic acid on the prognosis of diabetic micro- and macroangiopathy. Nutr Metab 24 (Suppl 1): 105–118, 1980.
- 48 Howard-Wiliams J, Patel P, Jelfs R, Carter RD, Awdry P, Bron A, Mann JI, Hockaday TDR: Polyunsaturated fatty acids and diabetic retinopathy. Br J Ophthalmol 69: 15–18, 1985.
- 49 Hyslop PA, York DA, Sauerheber RD: Effects of insulin on the lipid structure of liver plasma membrane measured with fluorescence and ESR spectroscopic methods. Biochim Biophys Acta 776: 267–278, 1984.
- 50 Isogai Y, Mochzuki K, Maeda T: Red cell filterability in diabetes. Scand J Clin Lab Invest 41 (Suppl 156): 171–173, 1981.
- 51
Jamal GA,
Carmichael H,
Weir AI:
Gammalinolenic acid in diabetic neuropathy.
Lancet
i: 1098,
1986.
10.1016/S0140-6736(86)91365-6 Google Scholar
- 52 Johnson PC, Doll SC, Cromey DW: Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450–457, 1986.
- 53 Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus. Medicine 47: 337–369, 1968.
- 54 Juhan I, Vague Ph, Buonocore M, Moulin JP, Jouve R, Vialettes B: Abnormalities of erythrocyte deformability and platelet aggregation in insulin-dependent diabetics corrected by insulin in vivo and in vitro. Lancet i: 535–537, 1982.
- 55 Juhan-Vague I, Rahmani-Jourdheuil D, Mishal Z, Roul C, Mourayre Y, Aillaud MF, Vague P: Correction by insulin added in vitro of abnormal membrane fluidity of the erythrocytes from type I (insulin-dependent) diabetic patients. Diabetologia 29: 417–420, 1986.
- 56 Kamada T, Otsuji S: Lower levels of erythrocyte membrane fluidity in diabetic patients: a spin label study. Diabetes 32: 585–591, 1983.
- 57 Kamada T, Yamashita T, Baba Y, Kai M, Setoyama S, Chuman Y, Otsuji S: Dietary sardine oil increases erythrocyte membrane fluidity in diabetic patients. Diabetes 35: 604–611, 1986.
- 58 Kelley VE, Winkelstein A, Izui S: Effects of prostaglandin E1 on immune complex nephritis in NZB X W mice. Lab Invest 14: 531–538, 1979.
- 59 Kikuchi Y, Koyama T, Koyama Y, Tozawa S, Arai T, Horimoto M, Kakiuchi Y: Red blood cell deformability in renal failure. Nephron 30: 8–14, 1982.
- 60 Komidori K, Kamada T, Yamashita T, Harada R, Otsuji Y, Hashimoto S, Chuman Y, Otsuji S: Erythrocyte membrane fluidity decreased in uremic hemodialysed patients. Nephron 40: 185–188, 1985.
- 61 Kon K, Maeda N, Shiga T: The influence of deformation of transformed erythrocytes during flow on the rate of oxygen release. J Physiol 339: 573–584, 1983.
- 62 Korthals JK, Maki T, Gieron MA: Nerve and muscle vulnerability to ischaemia. J Neurol Sci 71: 283–290, 1985.
- 63 Kury PG, Ramwell PW, McConnell HM: The effect of prostaglandin E1 and E2 on the human erythrocyte as monitored by spin labels. Biochim Biophys Res Commun 56: 478–483, 1974.
- 64
Landis EM:
Capillary pressure and capillary permeability.
Physiol Rev
14: 404–481,
1934.
10.1152/physrev.1934.14.3.404 Google Scholar
- 65 Larsson H, Valdemarsson S, Hedner P, Odeberg H: Reversal of increased whole blood and plasma viscosity after treatment of hypothryoidism in man. Acta Med Scand 217: 67–72, 1985.
- 66 Letcher RL, Chien S, Pickering TG, Sealey JE, Laragh JH: Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Am J Med 70: 1195–1202, 1981.
- 67 Lindahl O, Lindwall L, Spangberg A, Stenram A, Ockerman PA: A vegan regimen with reduced medication in the treatment of hypertension. Br J Nutr 52: 11–20, 1984.
- 68 Lorenz R, Spengler U, Fischer S, Duhm J, Weber PC: Platelet function, thromboxane formation and blood pressure control during supplementation of the western diet with cod liver oil. Circulation 67: 504–511, 1983.
- 69 Low PA, Nukada H, Schmelzer JD, Tuck RR, Dyck PJ: Endoneurial oxygen tension and radial topography in nerve edema. Brain Res 341: 147–154, 1985.
- 70 Low PA, Schmelzer JD, Ward KK, Yao JK: Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 250: E94–E99, 1986.
- 71 Low PA, Tuck RR: Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat. J Physiol 347: 513–524, 1984.
- 72 Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK: Prevention of some electro-physiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81: 8694–8698, 1984.
- 73 Lowe GDO, Lowe M, Drummond MM, Reith S, Belch JJF, Kessen CM, Wylie A, Foulds WS, Forbes CD, McCuish AC, Manderson WG: Blood viscosity in young diabetics with and without retinopathy. Diabetologia 18: 359–363, 1980.
- 74
Lundborg G.
Structure and function of the intraneural microvessels as related to trauma, edema formation, and nerve function.
J Bone Joint Surg
57A: 938–948,
1975.
10.2106/00004623-197557070-00011 Google Scholar
- 75 Lundborg G, Branemark P-I. Microvascular structure and function of peripheral nerves. Vital microscopic studies of the tibial nerve in the rabbit. Adv Microcirc 1: 66–88, 1968.
- 76 McManis PG, Low PA, Yao JK: Relationship between nerve blood flow and intercapillary distance in peripheral nerve edema. Am J Physiol 251: E92–E97, 1986.
- 77 McMillan DE: Disturbance of serum viscosity in diabetes mellitus. J Clin Invest 53: 1071–1079, 1974.
- 78 McMillan DE: Plasma protein changes, blood viscosity, and diabetic microangiopathy. Diabetes 25 (Suppl 2): 858–864, 1976.
- 79 McMillan DE, Utterback NG, Lee MM: A basis for the increased thixotropy of diabetic blood. Clin Hemorheol 5: 937–948, 1985.
- 80 Mahler F, Muheim MH, Intaglietta M, Bollinger A, Anliker M: Blood pressure fluctations in human nailfold capillaries. Am J Physiol 236: H888–H893, 1979.
- 81 Majno G, Palade GE, Schoefl GI: Studies on inflammation. II. The site of action of histamine and serotonin along the vascular tree: a topographic study. J Biophys Biochem Cytol 11: 607–626, 1961.
- 82 Maloon A, Fritz VU, Kaplan CL: Neurological complications of systemic vasculitis. A report of 2 cases. S Afr Med J 68: 603–605, 1985.
- 83 Margetts BM, Beilin LJ, Vandongen R, Armstrong BK: Vegetarian diet in mild hypertension: a randomised controlled trial. Br Med J 293: 1468–1471, 1986.
- 84 Mellick RS, Cavanagh JB: Changes in blood vessel permeability during degeneration and regeneration in peripheral nerves. Brain 91: 141–160, 1968.
- 85 Miller TL, Buhler DR: Effect of hexachlorophane on monovalent ion transport in human erythrocytes a mechanism for hexachlorophene-induced hemolysis. Biochim Biophys Acta 352: 86–96, 1974.
- 86 Millette TJ, Subramony SH, Wee AS, Harisdangkul V: Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy. Eur Neurol 25: 397–402, 1986.
- 87 Mohamed AH, Waterhouse JP, Friederici HHR: The fine structure of gingival terminal vascular bed. Microvasc Res 6: 137–152, 1973.
- 88 Moore PM, Fauci AS: Neurologic manifestations of systemic vasculitis. A retrospective and prospective study of the clinicopathologic features and response to therapy in 25 patients. Am J Med 71: 517–524, 1981.
- 89 Murphy ME, Johnson PC: Possible contribution of basement membrane to the structural rigidity of blood capillaries. Microvasc Res 9: 242–245, 1975.
- 90 Myers RR, Heckman HM, Powell HC. Endoneurial fluid is hypertonic. Results of microanalysis and its significance in neuropathy. J Neuropathol Exp Neurol 42: 217–224, 1983.
- 91 Myers RR, Mizisin AP, Powell HC, Lampert PW: Reduced nerve blood flow in hexachlorophene neuropathy. Relationship to elevated endoneurial fluid pressure. J Neuropathol Exp Neurol 41: 391–399, 1982.
- 92 Myers RR, Murakami H, Powell HC. Reduced nerve blood flow in edematous neuropathies: a biomechanical mechanism. Microvasc Res 32: 145–151, 1986.
- 93 Myers RR, Powell HC, Shapiro HM, Costello ML, Lampert PW: Changes in endoneurial fluid pressure, permeability and peripheral nerve ultrastructure in experimental lead neuropathy. Ann Neurol 8: 392–401, 1980.
- 94 Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD: Sural nerve oxygen tension in diabetes. Br Med J 293: 1053–1054, 1986.
- 95 Nielsen VK: Recovery from peripheral neuropathy after renal transplantation. Acta Scand Neurol 46 (Suppl 43): 207–208, 1970.
- 96 Niimi H, Sugihara M: Hemorheological approach to oxygen transport between blood and tissue. Biorheology 21: 445–461, 1984.
- 97 Niimi H, Sugihara M, Yamakawa T: Hemorheological factors of oxygen transfer in capillary tissue unit. Biorheology 20: 603–614, 1983.
- 98 Normandin DK: A proposed ultramicroscopic structure of the mammalian glomerular basement membrane. Trans Am Micros Soc 99: 60–78, 1980.
- 99 Nukada H: Increased susceptibility to ischemic damage in streptozotocin-diabetic nerve. Diabetes 35: 1058–1061, 1986.
- 100 Nukada H, Dyck PJ: Microsphere embolisation of nerve capillaries and fiber degeneration. Am J Pathol 115: 275–287, 1984.
- 101 Ohi T, Poduslo JF, Dyck PJ: Increased endoneurial albumin in diabetic polyneuropathy. Neurology (NY) 35: 1790–1791, 1985.
- 102 Ohsaka A, Suzuki K, Ohashi M: The spurting of erythrocytes through junctions of the vascular endothelium treated with snake venom. Microvasc Res 10: 208–213, 1975.
- 103 Olsson Y: The involvement of vasa nervorum in diseases of peripheral nerves, in PJ Vinken, GW Bruyn (eds): Handbook of Clinical Neurology, Vol. 12. Amsterdam, North-Holland, 1972, pp 644–664.
- 104 Olsson Y: Vascular permeability in the peripheral nervous system, in PJ Dyck, PK Thomas, EH Lambert, R Bunge (eds): Peripheral Neuropathy, 2nd ed. Philadelphia, Saunders, 1984, pp 579–597.
- 105 Ota M, Makino H, Takaya Y, Ofuji T: Molecular sieve in renal glomerular and tubular basement membranes as revealed by electron microscopy. Renal Physiol 3: 317–323, 1980.
- 106 Oughton J, Barnes AJ, Kohner EM: Diabetes mellitus: its effect on the flow properties of blood, in E Standl, H Mehnert (eds): Pathogenetic Concepts of Diabetic Microangiopathy. New York, Thieme-Stratton, 1981, pp 112–120.
- 107 Palinski W, Torsellini A, Doni L: Influence of platelet activation on erythrocyte deformability. Thromb Hemostas 49: 84–86, 1983.
- 108 Partridge BT, Simpson LO: Basal processes on duodenal epithelial cells of man, mouse and rat. Pathology 13: 463–472, 1981.
- 109 Parving, HH, Rossing N: Simultaneous determination of the transcapillary escape rate of albumin and IgG in normal and longterm juvenile diabetic subjects. Scand J Clin Lab Invest 32: 239–244, 1973.
- 110 Pettersson CAV, Tengvar C: Formation of oedema in transected rat sciatic nerve. Acta Neuropathol 70: 177–184, 1986.
- 111 Powell HC: Pathology of diabetic neuropathy: new observations, new hypotheses. Lab Invest 49: 515–518, 1983.
- 112 Powell HC, Myers RR, Lampert PW: Changes in Schwann cells and vessels in lead neuropathy. Am J Pathol 109: 193–205, 1982.
- 113 Powell HC, Myers RR, Zweifach BW, Lampert PW: Endoneurial pressure in hexachlorophene neuropathy. Acta Neuropathol 41: 139–144, 1978.
- 114 Powell HC, Rodriguez M, Hughes RAC: Microangiopathy of vasa nervorum in dysglobulinemic neuropathy. Ann Neurol 15: 386–394, 1984.
- 115 Powell HC, Rosoff J, Myers RR: Microangiopathy in human diabetic neuropathy. Acta Neuropathol 68: 295–305, 1985.
- 116 Rand PW, Norton JM, Lacombe E, Barker N, Pirone L: Haemorheological effects of hypoxia in diabetes mellitus. Microvasc Res 17: 515, 1979.
- 117 Rasmussen H, Lake W, Allen JE: The effect of catecholamines and prostaglandins upon human and rat erythrocytes. Biochim Biophys Acta 411: 63–73, 1975.
- 118 Riley PA, Seal P: The role of substituted anisoles in epidermal microinvasion. J Pathol 114: 1–7, 1974.
- 119 Rosenmund A, Binswanger U, Straub PW: Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialysed uremic patients. Ann Intern Med 82: 460–465, 1975.
- 120 Sawada H: The fine structure of the bovine Descemet's membrane with special reference to biochemical nature. Cell Tiss Res 226: 241–255, 1982.
- 121 Schmid-Schonbein H, Volger E: Red cell aggregation and red cell deformability in diabetes. Diabetes 25 (Suppl 2): 897–902, 1976.
- 122 Schoefl GI: Electron microscopic observations on the regeneration of blood vessels after injury. Ann NY Acad Sci 116: 789–802, 1964.
- 123 Schubotz R, Muhlfellner O: The effect of pentoxifylline on erythrocyte deformability and on phosphatide fatty acid distribution in the erythrocyte membrane. Curr Med Res Opin 4: 609–617, 1977.
- 124 Service FJ, Daube JR, O'Brien PC, Zimmerman BR, Swanson CJ, Brennan MD, Dyck PJ: Effect of blood glucose control on peripheral nerve function in diabetic patients. Mayo Clinic Proc 58: 283–289, 1983.
- 125 Service FJ, Rizza RA, Daube JR, O'Brien PC, Dyck PJ: Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy. Diabetologia 28: 722–727, 1985.
- 126 Shand BI: Changes in blood rheology induced by lactic acid. Proc Univ Otago Med Sch 64: 71–72, 1986.
- 127 Simpson LO: Basement membranes and biological thixotropy: a new hypothesis. Pathology 12: 377–389, 1980.
- 128 Simpson LO: Intrinsic stiffening of red blood cells as the fundamental cause of diabetic nephropathy and microangiopathy: a new hypothesis. Nephron 39: 344–351, 1985.
- 129 Simpson LO, Olds RJ, Hunter JA: Changes in rheological properties of blood in cigarette smokers taking Efamol: a pilot study. Proc Univ Otago Med Sch 62: 122–123, 1984.
- 130 Simpson LO, Shand BI, Olds RJ: Multiple sclerosis and Efamol, in JR Casley-Smith, NB Piller (eds): Progress in Lymphology X. Proceedings of the Xth International Congress in Lymphology. Adelaide, University of Adelaide Press, 1985, pp 282–284.
- 131 Simpson LO, Shand BI, Olds RJ: The effects of dietary supplementation with Efamol on the healing rate of intractable ulcers. NZ Family Phys 13: 68–70, 1986.
- 132 Simpson LO, Shand BI, Olds RJ, Larking PW, Arnott MJ: Red cell and haemorheological changes in multiple sclerosis. Pathology 19: 51–55, 1987.
- 133 Singer P, Berger I, Luck K, Taube C, Naumann E, Godicke W: Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 62: 259–265, 1986.
- 134 Skovborg F, Nielsen Aa V, Schlichtkrull J, Ditzel J: Blood viscosity in diabetic patients. Lancet i: 129–131, 1966.
- 135 Slavkin HC, Bringas P: Epithelial-mesenchyme interactions during odontogenesis. IV. Morphological evidence for direct heterotypic cell-cell contacts. Dev Biol 50: 428–442, 1976.
- 136 Smith DR, Kobrine AI, Rizzoli HV: Absence of autoregulation in peripheral nerve blood flow. J Neurol Sci 33: 347–352, 1977.
- 137 Starling EH: Elements of Human Physiology. London, J & A Churchill, 1892, p 196.
- 138 Sugimoto H, Monafo WW, Eliasson SG: Regional sciatic nerve and muscle blood flow in conscious and anaesthetised rats. Am J Physiol 251: H1211–H1216, 1986.
- 139 Sundqvist T, Oberg PA, Rapoport SI: Blood flow in rat sciatic nerve during hypotension. Exp Neurol 90: 139–148, 1985.
- 140 Tegner R, Lindholm B: Uremic polyneuropathy: different effects of hemodialysis and continuous ambulatory peritoneal dialysis. Acta Med Scand 218: 409–416, 1985.
- 141 Tibblin G, Bergentz S-E, Bjure J, Wilhelmsen L: Haematocrit, plasma protein, plasma volume and viscosity in early hypertensive disease. Am Heart J 72: 165–176, 1966.
- 142 Tillmann W, Merten A, Lakomek M, Gahr M, Fiechtl J, Schroter W: Flexibility of erythrocytes in juvenile diabetes mellitus. Blut 43: 125–128, 1981.
- 143 Timperley WR, Boulton AJM, Davies-Jones GAB, Jarratt JA, Ward JD: Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol 38: 1030–1038, 1985.
- 144 Timperley WR, Ward JD, Preston FE, Duckworth T, O'Malley BC: Clinical and histological studies in diabetic neuropathy. A reassessment of vascular factors in relation to intravascular coagulation. Diabetologia 12: 237–243, 1976.
- 145 Towfighi J, Gonatas NK, McCree L: Hexachloropheneinduced changes in central and peripheral myelinated axons of developing and adult rats. Lab Invest 31: 712–721, 1974.
- 146 Tuck RR, Schmeltzer JD, Low PA: Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950, 1984.
- 147 Vandergriff KD, Olson JS: Morphological and physiological factors affecting oxygen uptake and release by red blood cells. J Biol Chem 259: 12619–12627, 1984.
- 148 Van Doormaal JJ, Muskier FAJ, Martini IA, Doorenbos H: Changes in fatty acid profiles of plasma, erythrocytes and polymorphonuclear leukocytes in man: indirect evidence for altered delta 6 desaturase activity. Clin Chim Acta 156: 299–314, 1986.
- 149
Vital C,
Vallat IM,
Deminiere C,
Loubet A,
Leboutet MJ:
Peripheral nerve damage during multiple myeloma and Waldenstrom's macroglobulinemia. An ultrastructural and immunopathologic study.
Cancer
50: 1491–1497,
1982.
10.1002/1097-0142(19821015)50:8<1491::AID-CNCR2820500808>3.0.CO;2-Q CAS PubMed Web of Science® Google Scholar
- 150 Vracko R: Skeletal muscle capillaries in diabetes. A quantitative analysis. Circulation 41: 271–283, 1970.
- 151 Vracko R. Basal lamina layering in diabetes mellitus. Evidence for accelerated rate of cell death and cell regeneration. Diabetes 23: 94–104, 1974.
- 152 Warfel KA, Hull MT: Migration of lymphocytes through the cutaneous basal lamina in normal skin: an ultrastructural study. Anat Rec 208: 349–355, 1984.
- 153 Wees SJ, Sunwoo IN, Oh SJ: Sural nerve biopsy in systemic necrotising vasculitis. Am J Med 71: 525–532, 1981.
- 154 Williams E, Timperley WR, Ward JD, Duckworth T: Electron microscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33: 462–470, 1980.
- 155 Winkelstein A, Kelley VE: Effects of PGE1 in murine models of SLE: changes in circulating immune complexes. Clin Immunol Immunopathol 20: 188–192, 1981.
- 156 Yagihashi S, Matsunaga M: Ultrastructural pathology of peripheral nerves in patients with diabetic neuropathy. Tohoku J Exp Med 129: 357–366, 1979.
- 157 Yasuda H, Dyck PJ: Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathy. Neurology (NY) 37: 20–28, 1987.
- 158 Young RJ, Ewing DJ, Clarke BF: Nerve function and metabolic control in teenage diabetics. Diabetes 32: 142–147, 1983.
- 159 Zurier RB, Damjanov I, Sayadoff DM, Rothfield NF: Prostaglandin E1 treatment of NZB/NZW F1 hybrid mice. II. Prevention of glomerulonephritis. Arthritis Rheum 20: 1449–1456, 1977.